← Back to Search

Combination Product

Combination Wound Care for Hidradenitis Suppurativa

Phase 2

Waitlist Available

Led By Rita O Pichardo, MD

Research Sponsored by Wake Forest University Health Sciences

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Individuals with hidradenitis suppurativa with non-healing wounds or draining abscesses/nodules

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from week 4 to week 8

Awards & highlights

Study Summary

This trial is testing a combination wound care product of methylene blue, gentian violet, and ovine forestomach to see how well it heals wounds.

Who is the study for?

This trial is for adults over 18 with hidradenitis suppurativa (HS) who have non-healing wounds or draining abscesses/nodules. It's not open to those under 18 or without an HS diagnosis.Check my eligibility

What is being tested?

The study is testing the effectiveness of a wound care regimen using methylene blue, gentian violet, and ovine forestomach dressings on healing HS-related wounds.See study design

What are the potential side effects?

Potential side effects may include skin irritation, allergic reactions to the dressing materials, and discoloration of the skin where treatments are applied.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have hidradenitis suppurativa with wounds or abscesses that won't heal.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from week 4 to week 8

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from week 4 to week 8

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from week 4 to week 8 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Percent of Wound Healing

Wound Healing Time

Secondary outcome measures

Pain Assessment

Trial Design

1Treatment groups

Experimental Treatment

Group I: TreatmentExperimental Treatment1 Intervention

methylene blue, gentian violet, and ovine forestomach wound dressings to HS lesions

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor

1,239 Previous Clinical Trials

1,004,178 Total Patients Enrolled

3 Trials studying Hidradenitis Suppurativa

83 Patients Enrolled for Hidradenitis Suppurativa

Rita O Pichardo, MDPrincipal InvestigatorWake Forest University Health Sciences

1 Previous Clinical Trials

1 Trials studying Hidradenitis Suppurativa

Media Library

methylene blue, gentian violet, and ovine forestomach wound dressings (Combination Product) Clinical Trial Eligibility Overview. Trial Name: NCT04354012 — Phase 2

Hidradenitis Suppurativa Research Study Groups: Treatment

Hidradenitis Suppurativa Clinical Trial 2023: methylene blue, gentian violet, and ovine forestomach wound dressings Highlights & Side Effects. Trial Name: NCT04354012 — Phase 2

methylene blue, gentian violet, and ovine forestomach wound dressings (Combination Product) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04354012 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are methylene blue, gentian violet, and ovine forestomach wound dressings used to treat?

"Methylene blue, gentian violet, and ovine forestomach wound dressings are all effective treatments for infection, urethritis, and nephritis."

Answered by AI

Are there specific demographics that this research is recruiting?

"The inclusion criteria for this clinical trial requires that participants have hidradenitis and are between 18 and 75 years of age. Only 5 individuals will be accepted into the study."

Answered by AI

Has the FDA okayed using methylene blue, gentian violet, and ovine forestomach wound dressings?

"methylene blue, gentian violet, and ovine forestomach wound dressings have only been proven safe in Phase 2 trials. There is no available evidence that suggests these interventions are effective."

Answered by AI

Are there any remaining vacancies for this clinical trial?

"According to the information available on clinicaltrials.gov, this trial is no longer looking for patients. The trial was first posted on 1/1/2023 but was most recently updated on 10/26/2022. Even though this particular trial has completed recruitment, there are still many other trials (48 in total) that are currently looking for patients."

Answered by AI

Is the age limit for this clinical trial below seventy years old?

"The age limit for patients that this trial can accept is 75 years old. As long as patients are above 18 years old, they will be eligible for this study."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Hidradenitis Suppurativa Wound Care

2021. "Hidradenitis Suppurativa Wound Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04354012.

All > Hidradenitis Suppurativa